Home » EPIC Archives: AVCT (page 4)

AVCT News Archives

What is Affinity purification?

Avacta Group Plc

Affimer technology offers unique solutions in the field of affinity purification through the ability to develop highly specific and stable capture reagents for a wide-range of novel targets. The robust ...

Read Article »

Avacta Group Plc Wake-up call for the market

Hardman & Co

Avacta Group Plc (LON: AVCT) is a pre-clinical stage biotechnology company and the proprietary owner of Affimer technology. Affimers represent a radical alternative to the established antibody technology. The significant ...

Read Article »

Avacta In vivo expression of Affimers

Hardman & Co

Avacta Plc (LON:AVCT) is a pre-clinical biotechnology company and the proprietary owner of Affimer technology. Affimers represent a radical alternative to the established antibody technology, which continues to dominate the ...

Read Article »